Diabetic Nephropathy Prevention
Diabetic Nephropathy Prevention
Preventing diabetic kidney disease is largely a matter of doing unglamorous things consistently for years. This page sets out what can and cannot be prevented, how often to be screened, the targets that are aimed at and how long they take to reach, what to avoid outright, and what a follow-up plan actually looks like when it is written down.
Screening — the interval, and what is measured
Screening is two tests, and the whole point of it is that it happens when there is no reason to suspect anything. In type 1 diabetes it usually begins five years after diagnosis; in type 2 diabetes it begins at diagnosis, because the disease has often been present silently for years before it was found. The reason for both schedules is set out on the causes page.
| Situation | How often both tests are done |
|---|---|
| Type 1 diabetes, fewer than five years since diagnosis | Usually not yet — the disease rarely appears this early |
| Type 1 diabetes, five years or more since diagnosis | Annually |
| Type 2 diabetes, at any point after diagnosis | Annually, from diagnosis onward |
| Albuminuria confirmed, or filtration falling | Every six months, or at the interval your clinician sets from the slope |
| Filtration substantially reduced | More frequently, with the additional measurements that stage requires — potassium, acid status, haemoglobin and bone chemistry |
Both tests, every time. Checking the urine alone misses the people whose albumin stays normal while filtration declines; checking the filtration alone misses the earliest and most treatable stage. Neither omission is detectable after the fact, which is why the pairing is the rule rather than the preference.
The targets, and how long they take
Two targets carry most of the benefit, and both are reached over months rather than in a single visit. Blood pressure is generally aimed below a systolic of 130 mmHg in people with diabetes and kidney disease, with the exact figure set by tolerance and by how it is measured. Albuminuria is pushed as low as it can go, with a reduction from baseline of at least thirty per cent commonly used as the first milestone rather than a normal result as the aim.
| Target | What is realistic |
|---|---|
| Blood pressure | Reached in weeks to months, usually with more than one medicine. Home readings carry more weight than clinic ones |
| Albuminuria reduction | A substantial fall over three to six months of optimised treatment; a normal result is possible at the earlier grades and less so later |
| Long-term glucose average | Set by the stage of kidney disease — tightened early, relaxed as filtration falls |
| The slope of filtration over years | The target that matters most and is measured least often; a slowed slope is success even where no number has normalised |
Two caveats keep this honest. These are aims rather than guarantees — a target reachable in one person is not reachable in another, and the value of a target is that it makes a conversation possible. And they are measured over time: a single reading that misses is a reading, while three readings over six months are a trend, and the trend is what decisions are made from.
What protects the kidney day to day
Most of what patients can do for themselves sits in one short list, and the avoidable half of it is the half that causes emergencies.
| Action | What it achieves |
|---|---|
| Reduce sodium, especially in food bought or cooked by others | The single most effective dietary change: lower pressure, less albuminuria, and every medicine working better |
| Stop smoking | Slows filtration loss through vascular effects independent of glucose, and addresses the larger cardiovascular threat at the same time |
| Exercise regularly and keep to a weight you can maintain | Improves pressure, glucose and cardiovascular risk together |
| Keep vaccinations current | Infection is a common precipitant of a step down in filtration, and the step is not always recovered |
| Treat sleep apnoea if it is present | Untreated apnoea drives night-time pressure and is frequently missed |
| Measure blood pressure at home and bring the readings | Finds the uncontrolled night-time and morning pressure a clinic reading misses |
| Keep your own dated record of every result | A trend written down is the most useful thing a patient can bring to any appointment |
That last row is worth more than it appears. Albumin, filtration, potassium, glucose and blood pressure with dates, in one place — a spreadsheet, a notebook, or photographs of each clinic letter. A trend reconstructed from memory is not reliable, and a trend written down is what lets a clinician somewhere else give a considered opinion from your records alone.
What to avoid, and what to do when ill
One class of medicine comes before everything else: non-steroidal anti-inflammatory drugs — ibuprofen, naproxen, diclofenac and their relatives — taken regularly. They reduce blood flow to the kidney, and in a kidney whose filtration is already reduced they can produce a sudden step down that is not always recovered. Occasional use is a conversation with your clinician; regular use is not.
| Avoid | Why |
|---|---|
| Anti-inflammatory painkillers taken regularly | Reduce blood flow to the kidney; a common cause of a sudden step down in filtration |
| Contrast agents used without preparation | A risk that is small in a healthy kidney and larger in a scarred one; hydration and alternatives are arranged beforehand |
| Dehydration, including during illness and in hot weather | Repeated acute reductions in filtration leave permanent steps down |
| Supplements and herbal preparations taken silently | Some contain compounds that matter to the kidney or interact with prescribed medicines; the risk is only manageable if it is known |
| Skipping the annual test because you feel well | The disease has no symptoms at the stage where treating it changes the most |
And what to do when ill: agree a sick-day plan in advance, in writing. Its content is simple — which medicines to hold during a febrile illness, vomiting or diarrhoea; how much fluid to aim for; when to measure glucose more often; and the symptom threshold at which to seek assessment rather than wait. That plan is written into the summary you take home, and it is worth reading before you need it.
What a follow-up plan looks like
Follow-up in this disease is a small number of measurements repeated at a frequency set by risk. There is no scan schedule, no tumour marker and no need for repeated biopsies in the ordinary course; a biopsy is done when the answer would change the treatment, which is rare in a typical case.
| Element | What it contains |
|---|---|
| The two measurements and their dates | Urine albumin and filtration rate, at the interval your stage sets |
| Blood pressure, measured at home | With the target written next to it, so that a reading can be interpreted by you rather than only by us |
| A medicine list that is current | Including doses, and including everything bought without a prescription |
| The targets you are aiming at | So that a result can be read against something rather than in isolation |
| A sick-day plan | What to hold, how much to drink, and when to seek assessment |
| A review point with a date | The date the plan is revisited — because a plan without a date is a wish |
None of this is dramatic, and that is the point. The treatments that change the outcome in this disease are the ones still being taken in fifteen years, and the patient still measuring in fifteen years is the patient who still has their own kidney. What we can add from outside — a records review before any travel, an opinion on whether an atypical feature warrants a biopsy — is described on the practical questions page.